Time for implementing high-sensitivity cardiac troponin assays in emergency departments in Italy

[1] Twerenbold R(2017)Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction J Am Coll Cardiol 70 996-1012

[2] Boeddinghaus J(2021)2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationthe task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC) Eur Heart J 42 1289-1367

[3] Nestelberger T(2018)Fourth universal definition of myocardial infarction (2018) J Am Coll Cardiol 72 2231-2264

[4] Collet J-P(2015)High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study The Lancet 386 2481-2488

[5] Thiele H(2012)One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T Arch Intern Med 172 1211-1218

[6] Barbato E(2017)Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department PLoS ONE 12 e0187662-13

[7] Thygesen K(2023)Clinical and organizational impact of the use of different cardiac troponin assays for the diagnosis of myocardial infarction without persistent elevation of the ST segment at presentation (NSTEMI) in 12 Italian Emergency Departments (EDs): the TROCAR study Intern Emerg Med 345 7-undefined

[8] Alpert JS(2021)Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the start-antiplatelet registry Int J Cardiol undefined undefined-undefined

[9] Jaffe AS(undefined)undefined undefined undefined undefined-undefined

[10] Shah ASV(undefined)undefined undefined undefined undefined-undefined

[1] Twerenbold R(2017)Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction J Am Coll Cardiol 70 996-1012

[2] Boeddinghaus J(2021)2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationthe task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC) Eur Heart J 42 1289-1367

[3] Nestelberger T(2018)Fourth universal definition of myocardial infarction (2018) J Am Coll Cardiol 72 2231-2264

[4] Collet J-P(2015)High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study The Lancet 386 2481-2488

[5] Thiele H(2012)One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T Arch Intern Med 172 1211-1218

[6] Barbato E(2017)Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department PLoS ONE 12 e0187662-13

[7] Thygesen K(2023)Clinical and organizational impact of the use of different cardiac troponin assays for the diagnosis of myocardial infarction without persistent elevation of the ST segment at presentation (NSTEMI) in 12 Italian Emergency Departments (EDs): the TROCAR study Intern Emerg Med 345 7-undefined

[8] Alpert JS(2021)Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the start-antiplatelet registry Int J Cardiol undefined undefined-undefined

[9] Jaffe AS(undefined)undefined undefined undefined undefined-undefined

[10] Shah ASV(undefined)undefined undefined undefined undefined-undefined